Category: Finance
-
Cancer Diagnostics Company Gains $5M in Early Round Funds
On-Q-ity in Waltham, Massachusetts, a developer of cancer diagnostics technology, says it has added $5 million in series B financing, the second round of funding after initial start-up. Participants in the round are Mohr Davidow Ventures, Atlas Ventures, and Physic Ventures, all of which are current investors in the company. On-Q-Ty — short for Oncology…
-
Devices, Industrial Biotech Lead 2012 Life Science Funding
Funding for privately-held life sciences companies worldwide in the first six weeks of 2012 shows medical device developers and industrial biotechnology companies attracting the most equity capital, but drug developers engaging in the largest number of financing deals. The report by life sciences venture capital firm Burrill and Company was released on Friday. Burrill reports…
-
Companies Among Gates Foundation TB Biomarkers Awardees
The Bill and Melinda Gates Foundation awarded today $7.7 million in funding to identify biomarkers for diagnosing tuberculosis (TB) in low-resource settings. The 10 awards aim to promote research into TB biomarkers that leads to a simple, low-cost tool to quickly and accurately diagnose TB in developing countries. One of the primary grant recipients is…
-
Energy Dept Seeks $20M Battery/Storage Research Hub
The Department of Energy (DoE) says it will open competition for a new research center to speed development of advanced battery and energy storage technologies. The new energy innovation hub, as these programs are called, will have up to $20 million in funding in the current (2012) fiscal year. Energy innovation hubs bring together researchers…
-
InnoCentive Acquires London-Based OmniComplete
InnoCentive Inc. in Waltham, Massachusetts, a provider of open-innovation and crowdsourcing competitions, says it has acquired OmniCompete Limited based in London, U.K. that also conducts challenge contests. No financial terms were disclosed. InnoCentive says it plans to adds OmniComplete’s experience in big-ticket competitions to InnoCentive’s so-called Grand Challenges, contests with larger payouts. Among the larger…
-
Grants for Orphan Disease Academic-Industry Partnerships
The Wellcome Trust in the U.K. has unveiled new funding for academic-industry partnerships in early-stage research and development projects targeting orphan and neglected diseases. The Pathfinder Awards aim to encourage pilot research projects with potential for developing new products that address diseases affecting a small percentage of the population (orphan diseases) or conditions that that…
-
Challenge Seeks Sustainable Material Substitute for Wood
A new challenge on Innocentive seeks materials or processes that can be used create materials with the physical properties of softwoods, but are more sustainable than natural wood. The competition has a prize of $20,000 and a deadline of 31 March 2012 for submissions. InnoCentive in Waltham, Massachusetts is a company the conducts open-innovation crowd-sourcing…
-
Manchester to Host U.K. Graphene Research Institute
The Engineering and Physical Sciences Research Council (EPSRC) in the U.K. confirmed today that University of Manchester will host the U.K.’s national graphene institute, a facility for graphene research and commercialization activities planned for use by both scientists and businesses. University of Manchester is the home of Sir Andre Geim and Sir Kostya Novoselov, who…
-
Canadian Govt Opens Call for Personalized Medicines R&D
The Canadian government opened a matching grant competition for research proposals on personalized medicine. The call seeks research proposals that can take treatments from “one size fits all” to more precise treatments and interventions addressing specific characteristics of the individual, made possible by new diagnostic technologies that look at patients’ unique genetic signatures. The competition…
-
$600K Foundation Grant to Fund Cancer Genomics Research
The National Foundation for Cancer Research (NFCR) has awarded a $600,000 grant to the Translational Genomics Research Institute (TGen) in Phoenix and the University of Arizona in Tucson for the study of targeted cancer therapies. The three-year grant will enable TGen and the university to continue its NFCR Center for Targeted Cancer Therapies, created in…